These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8979141

  • 1. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B.
    Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Danaparoid sodium.
    Acostamadiedo JM, Iyer UG, Owen J.
    Expert Opin Pharmacother; 2000 May; 1(4):803-14. PubMed ID: 11249517
    [Abstract] [Full Text] [Related]

  • 4. Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    Bergqvist D.
    Aust N Z J Surg; 1998 Jul; 68(7):463-8. PubMed ID: 9669358
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct 10; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glycosaminoglycans: clinical use.
    Boneu B.
    Semin Thromb Hemost; 1996 Oct 10; 22(2):209-12. PubMed ID: 8807719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG.
    Haemostasis; 1992 Oct 10; 22(2):58-65. PubMed ID: 1379965
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New therapeutic options in DVT prophylaxis.
    Wille-Jørgensen P.
    Orthopedics; 2000 Jun 10; 23(6 Suppl):s639-42. PubMed ID: 10875428
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Anticoagulant therapy in pulmonary embolism].
    Charbonnier B, Pacouret G, Augusseau-Richard MP, Dessenne X, Pagot O.
    Arch Mal Coeur Vaiss; 1995 Nov 10; 88(11 Suppl):1755-61. PubMed ID: 8815836
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Danaparoid in the prevention of thromboembolic complications.
    Skoutakis VA.
    Ann Pharmacother; 1997 Nov 10; 31(7-8):876-87. PubMed ID: 9220051
    [Abstract] [Full Text] [Related]

  • 19. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L, Naudziūnas A, Unikauskas A.
    Medicina (Kaunas); 2003 Nov 10; 39(4):352-8. PubMed ID: 12738903
    [Abstract] [Full Text] [Related]

  • 20. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
    Meuleman DG.
    Semin Thromb Hemost; 1989 Oct 10; 15(4):370-2. PubMed ID: 2479103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.